Church of PeptidesSearch
Portrait of Octreotide
Saints · 1979

Octreotide

The Silencer

Switzerland

Octreotide mimics somatostatin, a hormone that restrains several other hormones and digestive secretions. Its established uses include selected patients with acromegaly and control of severe diarrhea or flushing in particular hormone-secreting tumor syndromes. It does not simply reset all hormones.

Evidence ladder: Approved human useApproved human use · product-specific labelsEducational record
ClassificationSaints
Evidence summaryApproved human use · product-specific labels
OriginSwitzerland
Scientific record

What the evidence says

Established role or proposed benefit

  • Suppresses selected hormone and gastrointestinal secretions.
  • Has established uses in acromegaly and certain neuroendocrine settings.

Side effects, risks, and limits

  • Gastrointestinal symptoms, gallstones, glucose changes, and cardiac effects can occur.
  • It is not a universal hormone-balancing treatment.
Doctide’s verdict

The Silencer has a specific job: reduce excess hormonal signals or troublesome secretions. Doctide keeps symptom relief, biochemical control, and treatment of the underlying disease in separate columns rather than calling them all a cure.

Documented history

Where the real story begins

Sandostatin labeling records initial US approval in 1988. The medicine translated somatostatin-like inhibition into a practical treatment for growth-hormone excess and certain secretory symptoms. Later long-acting formulations extended delivery, but their indications and suitability still depend on the specific product. Historical source.

Switzerland · 1979
Book of the Canon · comic scripture

The laboratory legend

Octreotide entered during a shouting match among five hormones and lowered every microphone. The room became useful, if slightly constipated.

This bold passage is invented comedy, not scientific or historical fact.
Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledger

Sources

Source links checked: October 4, 2026. This authoritative medication reference describes particular medicinal formulations and uses; it is not evidence for every preparation or off-label claim.

  1. MedlinePlus: medication-specific uses and precautions
  2. FDA Drugs@FDA database
  3. SANDOSTATIN injection prescribing information

Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.